Constellation Pharmaceuticals
GPTKB entity
Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:MorphoSys
|
| gptkbp:acquisitionYear |
2021
|
| gptkbp:focusesOn |
oncology
epigenetics |
| gptkbp:foundedYear |
2008
|
| gptkbp:founder |
gptkb:Charles_Roberts
gptkb:David_Allis gptkb:Jean-Philippe_Vert gptkb:Patrick_Trojer gptkb:Robert_Copeland gptkb:Yang_Shi |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Constellation Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:CPI-0610
gptkb:CPI-1205 |
| gptkbp:parentCompany |
gptkb:MorphoSys
|
| gptkbp:website |
https://www.constellationpharma.com/
|
| gptkbp:bfsParent |
gptkb:Third_Rock_Ventures
|
| gptkbp:bfsLayer |
6
|